(2021). Drug pricing investigation: industry spending on buybacks, dividends, and executive compensation: Staff report. Committee on Oversight and Reform, U.S. House of Representatives.
Chicago Style (17th ed.) CitationDrug Pricing Investigation: Industry Spending on Buybacks, Dividends, and Executive Compensation: Staff Report. [Washington, D.C.]: Committee on Oversight and Reform, U.S. House of Representatives, 2021.
MLA (9th ed.) CitationDrug Pricing Investigation: Industry Spending on Buybacks, Dividends, and Executive Compensation: Staff Report. Committee on Oversight and Reform, U.S. House of Representatives, 2021.
Warning: These citations may not always be 100% accurate.